CD274 and acute myeloid leukemia: AML cells also have higher surface expression of inhibitory immune checkpoints (such as PD-L1) compared to normal hematopoietic stem (HSCs) and progenitor cells (HSPCs) and higher expression of PD-1 is observed on T-cells of AML patients compared to healthy donors (95–102).